DLG1 and Alzheimer disease: However, there was a significant increase of PSD95 and SAP97 protein levels following soluble AD-brain extract treatment, regardless of Aβ status, compared to control, perhaps indicating a compensatory response or presence of potentially pro-synaptic factors within the extract (Supplementary Fig. 8).